Background: The aim of this study was to explore the inhibitory effect of baicalin on myocardial apoptosis induced by Ischemia-Reperfusion (I/R).
Methods: Sprague Dawley rats' heart and myocardial cells I/R model were established in vivo and vitro, then 100 mg/kg and 10 μmol/l baicalin were administrated, respectively. The experiment was randomly divided into 4 groups (n=10): Control; I/R; IR+DMEM; and I/R+baicalin groups. Postoperation, the Left Ventricular (LV) End-Diastolic Pressure (LVEDP), the maximum velocity of LV contraction (dP/dtmax) and the maximum velocity of LV diastole (dP/dtmin) were recorded by the transthoracic echocardiography; the myocardial apoptosis percentage was analyzed by Annexin VFITC/ PI and TUNEL staining, and the apoptosis gene and protein were detected by RT-PCR and western blot. Furthermore, the protein expression of the calcium-sensing receptor (CaSR) and ERK1/2 phosphorylation were observed by western blot and Fura-2-acetoxymethyl ester. Moreover, primary rats’ cardiomyocytes were cultured and ERK1/2 specific inhibitor PD98059 was added to the culture medium. The cell survival rate, vitality and apoptosis were detected by MTT, lactate dehydrogenase (LDH) and TUNEL staining assay Kit, respectively.
Results: Our present study showed that baicalin significantly improved LV hemodynamic parameters and myocardial apoptosis in myocardial I/R injury rats. Furthermore, we found that baicalin could down-regulate the protein expression of CaSR, but up-regulate the protein expression of ERK1/2. Furthermore, when the cells were pretreated with ERK1/2 inhibitor PD98059, the cells survival rate significantly decreased, but LDH activity and apoptosis significantly increased. The results indicated that the effect of baicalin on myocardial I/R injury could be inhibited by ERK1/2 inhibitor.
Conclusion: In conclusion, our data suggests that baicalin attenuates I/R-induced myocardial injury maybe through the suppression of the CaSR/ERK1/2 signaling pathway.
[http://dx.doi.org/10.1213/01.ANE.0000087066.71572.3F] [PMID: 14633550]
[http://dx.doi.org/10.1016/S0140-6736(00)02482-X] [PMID: 10963199]
[http://dx.doi.org/10.1016/S0022-2828(03)00005-1 ] [PMID: 12689815]
[http://dx.doi.org/10.1038/s41419-018-1192-7] [PMID: 30478254]
[http://dx.doi.org/10.1016/S1674-8301(10)60042-5 ] [PMID: 23554644]
[http://dx.doi.org/10.1007/s11010-011-1096-7] [PMID: 21984037]
[http://dx.doi.org/10.1161/01.RES.0000197781.20524.b9] [PMID: 16306447]
[http://dx.doi.org/10.1016/j.brainres.2008.02.025] [PMID: 18371938]
[http://dx.doi.org/10.1152/ajpheart.00163.2001] [PMID: 11834498]
[http://dx.doi.org/10.1038/s41598-018-19327-9] [PMID: 29348484]
[http://dx.doi.org/10.1371/journal.pone.0135988] [PMID: 26356837]
[http://dx.doi.org/10.1155/2017/4619720] [PMID: 28373901]